Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Natco Pharma: Board Meeting Intimation for Considering And Approve The Financial Results For The Period Ended September 30 2025 And 2Nd Interim Dividend For The Financial Year Ending 2025-26
News Announcement

Natco Pharma: Board Meeting Intimation for Considering And Approve The Financial Results For The Period Ended September 30 2025 And 2Nd Interim Dividend For The Financial Year Ending 2025-26

07-Nov-2025 Follow Value Research Online on Google download pdfDownload PDF Natco Pharma

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the financial results for the period ended September 30 2025 and 2nd Interim dividend for the Financial Year ending 2025-26

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.